Lexeo Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	35.01	121.47	77.34	135.86	29.37
Short-Term Investments	86.5	-	-	-	-
Cash & Short-Term Investments	121.52	121.47	77.34	135.86	29.37
Cash Growth	0.04%	57.06%	-43.08%	362.53%	-
Prepaid Expenses	4.6	2.83	2.34	0.13	-
Other Current Assets	-	-	0.37	0.7	0.03
Total Current Assets	126.12	124.29	80.05	136.68	29.41
Property, Plant & Equipment	10.56	12.26	13.78	0.17	-
Long-Term Investments	7.01	-	-	-	-
Other Long-Term Assets	3.25	3.25	3.25	0	0
Total Assets	146.94	139.81	97.08	136.86	29.41
Accounts Payable	6.42	3.79	2.68	3.06	0.04
Accrued Expenses	12.82	10.29	8.09	3.78	0.25
Current Portion of Leases	2.67	2.61	2.83	-	-
Current Income Taxes Payable	-	-	0.51	0.53	0.04
Current Unearned Revenue	-	-	-	0.05	0.14
Other Current Liabilities	0.94	0.55	0.24	0.03	0.22
Total Current Liabilities	22.85	17.24	14.35	7.45	0.7
Long-Term Leases	7.25	9.03	10.65	-	-
Other Long-Term Liabilities	-	-	-	-	3.01
Total Liabilities	30.1	26.27	25	7.45	3.71
Common Stock	0	0	-	0	0
Additional Paid-In Capital	397.13	295.37	2.49	0.57	0.01
Retained Earnings	-280.17	-181.84	-115.45	-56.17	-5.55
Treasury Stock	-0.02	-	-	-	-
Comprehensive Income & Other	-0.1	-	-	-	-
Total Common Equity	116.84	113.54	-112.95	-55.6	-5.54
Shareholders' Equity	116.84	113.54	72.08	129.41	25.7
Total Liabilities & Equity	146.94	139.81	97.08	136.86	29.41
Total Debt	9.92	11.64	13.48	-	-
Net Cash (Debt)	111.59	109.83	63.85	135.86	29.37
Net Cash Growth	1.61%	72.00%	-53.00%	362.53%	-
Net Cash Per Share	3.51	20.51	39.17	87.50	20.38
Filing Date Shares Outstanding	33.2	26.65	1.61	1.58	1.51
Total Common Shares Outstanding	33.07	26.65	1.61	1.58	1.51
Working Capital	103.28	107.06	65.7	129.24	28.71
Book Value Per Share	3.53	4.26	-70.28	-35.18	-3.66
Tangible Book Value	116.84	113.54	-112.95	-55.6	-5.54
Tangible Book Value Per Share	3.53	4.26	-70.28	-35.18	-3.66
Machinery	1.23	0.89	0.65	0.19	-
Leasehold Improvements	0.27	0.25	0.23	-	-

Updated Mar 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q